News and media
Teva Canada Limited, headquartered in Toronto, and Teva Canada Innovation, headquartered in Montréal, are part of Teva Pharmaceutical Industries Ltd., the world’s largest generic drug maker. We’re proud to have been part of Canadian healthcare for more than 50 years, to market more than 400 medications across the country and to employ more than 1,000 Canadians.
If you’re looking for information about our company, please contact Public Affairs at Teva Canada Limited at
As the COVID-19 situation evolves globally, we are striving to provide an uninterrupted supply of medicines to the 200 million patients that we serve around the world.
The global emergency surrounding COVID-19 is disrupting the family, work and social lives of many people around the world.
At Teva, we’re working hard to keep the flow of medicines going to patients and healthcare systems. Thousands of colleagues have adapted the way they operate in order to continue performing essential work on our production lines, warehouses and distribution networks.
See how Teva is working to keep medicines moving.
Recognizing National Caregiver Day during COVID-19 (April 7, 2020)
COVID-19 is increasing the number of Canadians requiring caregiver information and support. Learn about how to protect yourself and others in the home, as well as those in your community (March 24, 2020)
Teva Canada Economic Impact Report (January 31, 2020)